Pfizer Inc. (NYSE:PFE) after opening the company’s stock at the price of $32.20, its shares traded on -0.03% below secure line. The stock exchanged hands 23,597,891 shares versus average trading capacity of 22.37M shares. It has a market cap of $189.70B.

Wall Street analysts are predicting that Pfizer Inc. (NYSE:PFE) will report earnings per share of $0.66 in their quarterly report. The firm is expected to announce results on 8/1/17.

For the current quarter Pfizer Inc. (NYSE:PFE) has high EPS estimates of $0.7 in contradiction of low EPS estimates of $0.62. However a year ago for the same quarter the company has reported $0.64 EPS. Average estimation for the current quarter has been provided by 15 analysts.

Investors as well as the sell-side will be paying close attention to how the actual numbers compare with the estimates. Earnings surprises can have a huge impact on a company’s stock price. Several studies suggest that positive earnings surprises not only lead to an immediate hike in a stock’s price, but also to a gradual increase over time. Hence, it’s not surprising that some companies are known for routinely beating earning projections. A negative earnings surprise will usually result in a decline in share price.

A large surprise factor in either direction typically can lead to a significant swing in the stock price in the hours and days after the report. Previously Pfizer Inc. (NYSE:PFE) reported $0.69 earnings per share (EPS) for the quarter on 5/2/2017 Before Market Open, beating the consensus estimate of $0.67 by $0.02 with surprise factor of 2.99%.

Pfizer Inc. (NYSE:PFE) has average revenue estimates of $13.06B, compared to low analyst estimates of $12.84B and high estimates of $13.29B for the current quarter. A total number of 13 analysts provided estimations over revenues. For the next quarter the company has anticipated average revenues of $13.12B, according to the sentiments of 13 analysts.

Taking a broader look at the analyst consensus, most recently Pfizer Inc. (NYSE:PFE)’s price target was revised on 05/15/17 and according to 19 analysts stock’s price will reach at $37.53 during 52 weeks with standard deviation of 5.44. Pfizer Inc. (NYSE:PFE)’s  minimum price target estimates has been figured out at $31.00 while the maximum price target forecast is established at $52.00, if we look at the price target with an optimistic approach it has upside potential of 61% from its latest closing price of $32.22.

On the other hand Pfizer Inc. (NYSE:PFE) has Relative Strength Index (RSI 14) of 20.20 along with Average True Range (ATR 14) of 0.33, where the relative strength index (RSI) is a technical momentum indicator that compares the magnitude of recent gains to recent losses in an attempt to determine excess buying & selling conditions of an asset, it is one of the most popular technical indicators, computed on the basis of the speed and direction of a stock’s price movement. The RSI value will always move between 0 and 100; the value will be 0 if the stock falls on all 14 days, and 100, if the price moves up on all the days) as suggested by J Welles Wilder. In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. The level of 50 represents neutral market momentum and corresponds with the center line in other oscillators such as MACD (Moving Average Convergence/Divergence). The average true range (ATR) is a measure of volatility introduced by Welles Wilder. Consequently Pfizer Inc. (NYSE:PFE)’s weekly and monthly volatility is 1.04%, 0.93% respectively.

In terms of Buy, Sell or Hold recommendations, Pfizer Inc. (NYSE:PFE) has an average broker recommendation of 2.29. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell. There are currently 14 recommendations in total that have been tracked in order to arrive at this number, of those, 6 have given the shares a Strong Buy while 0 are recommending a Buy, 7 have given the stock a Hold rating, 0 a Sell and 1 a Strong Sell.